CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 97 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,893,300 | -12.8% | 666,661 | 0.0% | 0.56% | -17.4% |
| Q3 2022 | $4,467,000 | +110.2% | 666,661 | +32.1% | 0.68% | +102.7% |
| Q2 2022 | $2,125,000 | -9.2% | 504,661 | +267.8% | 0.34% | +53.0% |
| Q1 2017 | $2,340,000 | +106.7% | 137,212 | +24.7% | 0.22% | -1.4% |
| Q4 2016 | $1,132,000 | +12.0% | 110,000 | +10.0% | 0.22% | +20.0% |
| Q3 2016 | $1,011,000 | -10.0% | 100,000 | 0.0% | 0.18% | -22.9% |
| Q2 2016 | $1,123,000 | -17.8% | 100,000 | 0.0% | 0.24% | -16.4% |
| Q1 2016 | $1,366,000 | – | 100,000 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,253,000 | $7,097,000 | 0.26% |
| INGALLS & SNYDER LLC | 1,358,573 | $4,280,000 | 0.19% |
| RA Capital Management | 3,033,603 | $9,556,000 | 0.17% |
| Kensington Investment Counsel, LLC | 85,483 | $269,000 | 0.16% |
| Perceptive Advisors | 4,301,282 | $13,548,000 | 0.10% |
| NewEdge Wealth, LLC | 381,326 | $1,201,000 | 0.05% |
| Black Diamond Financial, LLC | 46,000 | $145,000 | 0.05% |
| Birchview Capital, LP | 20,000 | $63,000 | 0.04% |
| XTX Topco Ltd | 14,305 | $45,000 | 0.02% |
| Alyeska Investment Group, L.P. | 548,090 | $1,726,000 | 0.02% |